Chengyu Wang
Researcher in Child and Adolescent Psychiatry at the Affiliated Brain Hospital of Guangzhou Medical University
Papers
Trials
Key Impact
He is a coauthor on multiple clinical ketamine and esketamine studies examining antidepressant, antisuicidal, cognitive, and neuroimaging effects in depression and suicidality.
Background & Research
Chengyu Wang appears to be a clinician-researcher based at the Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital) in Guangzhou, China. Across several studies, he has coauthored work on repeated intravenous ketamine and esketamine for major depressive disorder, suicidal ideation, cognition, and functional brain connectivity. The papers place him within a research group focused on biological and clinical mechanisms of rapid-acting antidepressant treatments.
Collaboration Network
6 collaborators· click a node to visit their profile
Full network →